These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction. Daviskas E, Robinson M, Anderson SD, Bye PT. J Aerosol Med; 2002; 15(3):331-41. PubMed ID: 12396422 [Abstract] [Full Text] [Related]
28. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R. Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142 [Abstract] [Full Text] [Related]
29. [Inhalation of hypertonic saline: a promising therapy in bronchiectasis]. Koskela H, Purokivi M. Duodecim; 2011 Jan; 127(24):2653-9. PubMed ID: 22320108 [Abstract] [Full Text] [Related]
30. Inhalation of dry-powder mannitol increases mucociliary clearance. Daviskas E, Anderson SD, Brannan JD, Chan HK, Eberl S, Bautovich G. Eur Respir J; 1997 Nov; 10(11):2449-54. PubMed ID: 9426077 [Abstract] [Full Text] [Related]
31. Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis. Daviskas E, Anderson SD, Eberl S, Young IH. Eur Respir J; 2008 Apr; 31(4):765-72. PubMed ID: 18057051 [Abstract] [Full Text] [Related]
32. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Kellett F, Robert NM. Respir Med; 2011 Dec; 105(12):1831-5. PubMed ID: 22018993 [Abstract] [Full Text] [Related]
33. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis. Chorepsima S, Kechagias KS, Kalimeris G, Triarides NA, Falagas ME. Drug Des Devel Ther; 2018 Dec; 12():4059-4066. PubMed ID: 30568427 [Abstract] [Full Text] [Related]
34. Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis. Main E, Grillo L, Rand S. Semin Respir Crit Care Med; 2015 Apr; 36(2):251-66. PubMed ID: 25826592 [Abstract] [Full Text] [Related]
35. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis. Nicolson CH, Stirling RG, Borg BM, Button BM, Wilson JW, Holland AE. Respir Med; 2012 May; 106(5):661-7. PubMed ID: 22349069 [Abstract] [Full Text] [Related]
36. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis. Minasian C, Wallis C, Metcalfe C, Bush A. Pediatr Pulmonol; 2008 Nov; 43(11):1078-1084. PubMed ID: 18972410 [Abstract] [Full Text] [Related]
38. The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis. Aksamit T, Bandel TJ, Criollo M, De Soyza A, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R. Contemp Clin Trials; 2017 Jul; 58():78-85. PubMed ID: 28495619 [Abstract] [Full Text] [Related]
39. Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital. Altenburg J, Wortel K, van der Werf TS, Boersma WG. Neth J Med; 2015 May; 73(4):147-54. PubMed ID: 25968285 [Abstract] [Full Text] [Related]
40. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Robinson M, Daviskas E, Eberl S, Baker J, Chan HK, Anderson SD, Bye PT. Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]